3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Lymphoma
17
Leukemia, Myeloid, Acute
16
Breast Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma, Non-Hodgkin
11
Carcinoma, Non-Small-Cell Lung
11
Lymphoma, Mantle-Cell
10
Leukemia
10
Lymphoma, Follicular
9
Hodgkin Disease
9
Myelodysplastic Syndromes
8
Recurrence
7
Neuroblastoma
7
Neoplasm Metastasis
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Brain Neoplasms
7
Neoplasms, Plasma Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Lung Neoplasms
6
Glioblastoma
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, B-Cell
5
Immunoblastic Lymphadenopathy
5
Burkitt Lymphoma
5
Interventions
Vincristine
12
Temozolomide
11
Irinotecan
10
Cyclophosphamide
10
Melphalan
8
Filgrastim
8
Etoposide
7
Ifosfamide
6
Granulocyte Colony-Stimulating Factor
6
Doxorubicin
6
Vinorelbine
5
Gemcitabine
5
Busulfan
5
Thiotepa
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Dactinomycin
4
pegfilgrastim
3
liposomal doxorubicin
3
irinotecan sucrosofate
3
fludarabine
3
etoposide phosphate
3
Stem Cell Transplantation
3
Sirolimus
3
Proton Therapy
3
Cisplatin
3
Carboplatin
3
Bone Marrow Transplantation
3
thymoglobulin
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rhabdomyosarcoma
×
Vorinostat
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled